Evolution Mining Ltd (EVN)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 11.69 |
|---|---|
| 52-week range | 9.79 – 17.75 |
| Return, 1 month / 3 months | −14.7% / +3.0% |
| Return, 1 year / 3 years | +12.7% / +249.2% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 53.1% |
| Worst drawdown (1 year) | -41.0% |
| Average daily value traded | 132.86M AUD |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Evolution Mining is an Australian gold miner that explores for, develops and operates mines, producing gold along with copper as a by-product. Its operations are spread across Australia, including underground and open-pit mines and processing plants in New South Wales, Queensland and Western Australia. The company supplies gold doré and concentrate to refiners and smelters, and it is headquartered in Perth, Western Australia.
On this site Evolution Mining Ltd appears as a stock on the Australian Securities Exchange (Australia), code EVN, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Evolution Mining Ltd (EVN) trades on the Australian Securities Exchange in Australia. It last closed at AUD 11.69 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 348 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.7% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -10.6% | ||
| From 52-week high | -33.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | -9.3% | ||
| 12-month return, skipping the last month | 32.2% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 132.86M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −14.7% |
| 3 months | +3.0% |
| 6 months | −9.3% |
| 1 year | +12.7% |
| 3 years | +249.2% |
| 5 years | +253.1% |
Signals
| 50-day / 200-day average | 13.60 / 13.08 |
|---|---|
| Golden / death cross (60 days) | Golden, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2026 | AUD 0.2100 |
| 3 Mar 2026 | AUD 0.2000 |
| 3 Sep 2025 | AUD 0.1300 |
| 4 Mar 2025 | AUD 0.0700 |
| 29 Aug 2024 | AUD 0.0500 |
| 27 Feb 2024 | AUD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.